共 75 条
- [1] Zimmer L(2015)Phase II DeCOG-study of ipilimumab in pretreated and treatment-naive patients with metastatic uveal melanoma PLoS One 10 e0118564-2405
- [2] Vaubel J(2014)Effect of selumetinib vs chemotherapy on progression-free survival in uveal melanoma: a randomized clinical trial JAMA 311 2397-617
- [3] Mohr P(2005)Population-based incidence of uveal melanoma in various races and ethnic groups Am J Ophthalmol 140 612-43
- [4] Carvajal RD(2003)TAE therapy for metastatic melanoma to liver (in Japanese) MB Derma 77 38-961
- [5] Sosman JA(2003)Incidence of uveal melanoma in the United States: 1973–1997 Ophthalmology 110 956-1670
- [6] Quevedo JF(1995)Treatment of uveal melanoma metastatic to the liver: a review of the M. D. Anderson Cancer Center experience and prognostic factors Cancer 76 1665-81
- [7] Hu DN(2013)Ipilimumab activity in advanced uveal melanoma Melanoma Res 23 79-602
- [8] Yu GP(2009)Frequent somatic mutations of GNAQ in uveal melanoma and blue naevi Nature 457 599-2199
- [9] McCormick SA(2010)Mutations in GNA11 in uveal melanoma N Engl J Med 363 2191-1413
- [10] Fujisawa Y(2010)Frequent mutation of BAP1 in metastasizing uveal melanomas Science 330 1410-135